Latest News

Innovative UC start-up gives back to community during COVID-19...

August 5, 2020

By Adam Cline When the area non-profit Locally Fed began just a couple of months ago, things happened fast. Started by UC students, including College of Arts and Sciences Journalism graduate Madalyn Norman, and current students Madi Rinaldi and Emily Buck, the organization was designed as an innovative solution to a unique challenge: helping feed Cincinnati during the COVID-19 pandemic and support restaurants hit hard by the crisis. To get started, the women solicited donations from friends and family to buy meals from local eateries. They also reached out to different publications to get the word out and keep the donations coming in.

UC's academic services help students navigate uncertain times

July 20, 2020

When COVID-19 first hit the University of Cincinnati (UC), College of Arts & Sciences (A&S) student Claire Kelley began to struggle. Kelley was in the midst of figuring out what major she wanted to transfer into. “I struggled to make the decision, but after meeting with my advisor, I felt more confident,” says Kelley. She had to declare her new path for school, a double major in biology and neuroscience, from home which was stressful for her. However, her academic advisor walked her through every step of the process and helped her plan for the upcoming year and even into the future all through email and phone calls. “My advisor was so helpful and really helped me through the difficult time,” says Kelley.

UC COVID-19 research examines the safety and efficacy of immune...

July 15, 2020

Researchers at UC are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial. The research trial, called Sirolimus Treatment in Hospitalized Patients with COVID-19 Pneumonia (SCOPE), will examine the Food and Drug Administration-approved medication that is most commonly used to prevent organ rejection in patients with kidney transplants. It is also FDA-approved for the treatment of a rare lung disease, LAM.

Load More
Debug Query for this